Invesco’s Avadel Pharmaceuticals AVDL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.63M | Buy |
748,875
+699,201
| +1,408% | +$6.19M | ﹤0.01% | 2032 |
|
|
2025
Q1 | $389K | Sell |
49,674
-2,468
| -5% | -$19.3K | ﹤0.01% | 3241 |
|
|
2024
Q4 | $548K | Buy |
52,142
+1,177
| +2% | +$12.4K | ﹤0.01% | 3183 |
|
|
2024
Q3 | $668K | Buy |
50,965
+3,014
| +6% | +$39.5K | ﹤0.01% | 3088 |
|
|
2024
Q2 | $674K | Buy |
+47,951
| New | +$674K | ﹤0.01% | 3139 |
|
|
2020
Q4 | – | Sell |
-385,892
| Closed | -$1.95M | – | 3729 |
|
|
2020
Q3 | $1.95M | Sell |
385,892
-349,229
| -48% | -$1.76M | ﹤0.01% | 2502 |
|
|
2020
Q2 | $5.94M | Buy |
735,121
+2,109
| +0.3% | +$17K | ﹤0.01% | 1896 |
|
|
2020
Q1 | $5.82M | Buy |
+733,012
| New | +$5.82M | ﹤0.01% | 1792 |
|
|
2016
Q2 | – | Sell |
-398,870
| Closed | -$4.4M | – | 3654 |
|
|
2016
Q1 | $4.4M | Sell |
398,870
-45,854
| -10% | -$506K | ﹤0.01% | 1962 |
|
|
2015
Q4 | $5.43M | Buy |
444,724
+86,049
| +24% | +$1.05M | ﹤0.01% | 1850 |
|
|
2015
Q3 | $5.85M | Sell |
358,675
-152,834
| -30% | -$2.49M | ﹤0.01% | 1774 |
|
|
2015
Q2 | $10.8M | Buy |
511,509
+142,785
| +39% | +$3.03M | ﹤0.01% | 1518 |
|
|
2015
Q1 | $6.63M | Buy |
368,724
+160,096
| +77% | +$2.88M | ﹤0.01% | 1781 |
|
|
2014
Q4 | $3.57M | Buy |
208,628
+207,915
| +29,161% | +$3.56M | ﹤0.01% | 2136 |
|
|
2014
Q3 | $10K | Buy |
713
+72
| +11% | +$1.01K | ﹤0.01% | 4031 |
|
|
2014
Q2 | $10K | Buy |
+641
| New | +$10K | ﹤0.01% | 4012 |
|
|
2014
Q1 | – | Sell |
-78,346
| Closed | -$631K | – | 4092 |
|
|
2013
Q4 | $631K | Sell |
78,346
-4,929
| -6% | -$39.7K | ﹤0.01% | 3353 |
|
|
2013
Q3 | $546K | Sell |
83,275
-63,793
| -43% | -$418K | ﹤0.01% | 3361 |
|
|
2013
Q2 | $903K | Buy |
+147,068
| New | +$903K | ﹤0.01% | 2935 |
|